GO:2000278 regulation of DNA biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000278 regulation of DNA biosynthetic process describes any process that modulates the frequency, rate or extent of DNA biosynthesis, encompassing nucleotide supply, replication licensing, chromatin context and transcriptional control.
• Nucleotide metabolism and biosynthesis provide the precursor pool that rate-limits DNA synthesis, and this pool is dynamically regulated by nutrient and growth signals.
• Nuclear receptors and transcription factors can directly or indirectly modulate DNA synthesis by controlling gene expression programs, though DNA binding and regulatory output are often uncoupled.
• Chromatin remodeling, SUMO modification and DNA methylation status influence the accessibility of DNA templates and thus the efficiency of DNA biosynthetic processes.
• Human ORC2 is a core licensing factor whose regulation affects epigenetics and chromosome structure, linking replication initiation to global DNA biosynthetic capacity.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal dissection of regulators of DNA biosynthesis in disease and development.
Description
Regulation of DNA biosynthetic process (GO:2000278) is a biological process ontology term that captures any mechanism controlling the frequency, rate or extent of DNA biosynthesis. DNA biosynthesis includes both the replication of the genome and the de novo synthesis of DNA precursors, and its regulation is essential for genome stability, cell proliferation and development. Because DNA synthesis must be coordinated with nucleotide availability, cell cycle progression and chromatin state, multiple layers of control converge on this process. Understanding GO:2000278 is therefore central to cancer biology, developmental biology and regenerative medicine, where misregulated DNA synthesis drives pathology or limits tissue repair. Researchers use this term to annotate genes and pathways that modulate DNA production, from metabolic enzymes to replication licensing factors and chromatin regulators. The term is distinct from the DNA biosynthetic process itself (GO:0006260) because it specifically describes the modulatory inputs that set the rate and extent of synthesis.
regulation of DNA biosynthetic process At A Glance
| GO ID | GO:2000278 |
|---|---|
| GO term | regulation of DNA biosynthetic process |
| Ontology | biological_process |
| Definition | Any process that modulates the frequency, rate or extent of DNA biosynthetic process. |
| Synonyms | regulation of DNA anabolism; regulation of DNA biosynthesis; regulation of DNA formation; regulation of DNA synthesis |
| Major function | Controls the rate and extent of DNA synthesis by modulating nucleotide supply, replication initiation, fork progression and chromatin accessibility. |
| Related processes | Nucleotide metabolism, cell cycle control, chromatin remodeling, epigenetic regulation. |
| Key regulators | Nuclear receptors, transcription factors, ORC complex, SUMO machinery, DNA methylation enzymes. |
| Disease relevance | Cancer, developmental disorders, metabolic syndromes and degenerative diseases. |
What Is GO:2000278?
In our own words, GO:2000278 encompasses any biological process that changes how much, how fast or how often DNA is synthesized. This includes regulation of nucleotide precursor supply, control of replication origin firing, modulation of replication fork progression, and the influence of chromatin and epigenetic states on DNA synthesis. It is a parent term that groups specific regulatory processes such as regulation of DNA replication and regulation of nucleotide biosynthetic process, and it is used to annotate gene products that act as upstream controllers rather than the core synthetic machinery itself.
Why Is regulation of DNA biosynthetic process Important in Cell Biology?
Regulation of DNA biosynthetic process is fundamental because DNA synthesis must be tightly controlled to maintain genome integrity and to support cell proliferation only when appropriate. Dysregulation of this process can lead to mutations, aneuploidy and uncontrolled growth, which are hallmarks of cancer. Conversely, insufficient DNA synthesis contributes to developmental defects and aging-related pathologies. Understanding the regulatory inputs of GO:2000278 provides therapeutic targets and biomarkers for diseases characterized by abnormal proliferation or genome instability.
• Controls cell cycle progression and genome duplication fidelity.
• Integrates nutrient and growth factor signals with DNA synthesis via nucleotide metabolism.
• Links chromatin structure and epigenetic marks to DNA replication efficiency.
• Modulates replication origin licensing through ORC components such as ORC2.
• Influences transcription factor networks that indirectly regulate DNA synthesis genes.
• Implicated in cancer development through oncogenic activation of DNA synthesis.
• Affects developmental processes and tissue regeneration.
• Provides targets for chemotherapeutic and targeted therapies.
• Regulated by SUMOylation and chromatin remodeling complexes.
• Can be studied with CRISPR screens to identify novel regulators.
What Happens During regulation of DNA biosynthetic process?
Nucleotide precursor supply
In simple terms: The cell must have enough building blocks (nucleotides) to make DNA.
Regulation of DNA biosynthesis begins with the availability of nucleotide precursors. Nucleotide metabolism and biosynthesis are dynamically regulated to match the demand for DNA synthesis, and this regulation is responsive to nutrient status and growth signals. Key enzymes in purine and pyrimidine biosynthesis are controlled at transcriptional and post-translational levels, ensuring that the pool of dNTPs supports replication without causing mutagenic imbalances.
Replication licensing and initiation
In simple terms: The cell marks specific spots on DNA where copying can start.
The origin recognition complex (ORC) and associated factors license replication origins for firing. Human ORC2 is a core component that not only initiates replication but also influences epigenetics and chromosome structure, thereby regulating the overall capacity for DNA synthesis. Regulation of licensing ensures that the genome is copied exactly once per cell cycle, preventing re-replication and genomic instability.
Chromatin and epigenetic modulation
In simple terms: How tightly DNA is packaged affects how easily it can be copied.
Chromatin remodeling and DNA methylation status modulate access of the replication machinery to DNA. Hypomethylation of DNA has been linked to regulation of gene expression and can influence DNA synthesis indirectly by altering chromatin state. SUMO modification of chromatin remodeling factors adds another layer of control over DNA-templated processes, including DNA biosynthesis.
Transcriptional and signaling control
In simple terms: Signals from outside the cell can turn DNA copying up or down.
Nuclear receptors and transcription factors respond to hormonal and metabolic signals to regulate genes involved in DNA synthesis. However, transcription factor DNA binding and regulatory targets can have low overlap, meaning that DNA binding alone does not predict regulatory output on DNA biosynthetic genes. Signaling pathways such as FoxO integrate stress and growth signals to modulate DNA synthesis and cell cycle progression.
Co-regulation with metal homeostasis
In simple terms: Metals like zinc or iron can affect DNA copying through shared regulatory mechanisms.
A through-DNA mechanism has been described for co-regulation of metal uptake and efflux, illustrating how DNA itself can act as a conduit for regulatory crosstalk that impacts DNA biosynthetic processes. This highlights the integration of metal homeostasis with DNA metabolism and its regulation.
Key Genes Involved in GO:2000278 regulation of DNA biosynthetic process
The following genes and proteins are established regulators or effectors of DNA biosynthetic processes, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ORC2 | Origin recognition complex subunit; replication licensing and chromatin structure | Knockout studies reveal essential role in DNA synthesis and epigenetics |
| FOXO | Transcription factor integrating growth and stress signals to regulate DNA synthesis and cell cycle | Point mutations inform on cancer and longevity pathways |
| NR superfamily | Nuclear receptors that transcriptionally regulate metabolic and DNA synthesis genes | Structural and functional studies guide drug design |
| SUMO machinery | Post-translational modification of chromatin remodelers affecting DNA biosynthesis | Knockout of SUMO enzymes alters DNA synthesis regulation |
| DNA methyltransferases | Establish DNA methylation patterns that influence chromatin and DNA synthesis | Knockout models show hypomethylation effects on gene expression |
| Nucleotide biosynthetic enzymes | Provide dNTP precursors for DNA synthesis | Targets for metabolic inhibitors and CRISPR screens |
| Transcription factors | Regulate expression of DNA synthesis genes, though binding and function can be uncoupled | CRISPR knockout to dissect regulatory networks |
| Metal transporters | Co-regulated with DNA processes via through-DNA mechanisms | Models to study metal-DNA crosstalk |
| ORC1 | Replication licensing factor | Comparative studies with ORC2 |
| CDC6 | Loading of MCM complex during licensing | Knockout causes replication defects |
| CDT1 | Licensing factor | Overexpression models for re-replication |
| MCM2-7 | Replicative helicase | Point mutations affect fork progression |
| PCNA | Processivity factor for DNA polymerases | Knock-in tags for imaging |
| POLA1 | DNA polymerase alpha | Knockout is lethal; conditional models needed |
| RRM1 | Ribonucleotide reductase subunit | Target for cancer therapy |
| TYMS | Thymidylate synthase | Drug target in cancer |
| DHFR | Dihydrofolate reductase | Model for antifolate resistance |
How Is regulation of DNA biosynthetic process Regulated?
Regulation of DNA biosynthetic process is itself regulated at multiple levels. Nutrient and growth factor signaling, including insulin/IGF and mTOR pathways, controls nucleotide biosynthesis and DNA replication. The FoxO transcription factors integrate oxidative stress and growth signals to modulate DNA synthesis and cell cycle arrest. SUMOylation of chromatin remodeling complexes provides a dynamic switch for DNA-templated processes. Additionally, metal homeostasis can co-regulate DNA biosynthesis through through-DNA mechanisms. These layers ensure that DNA synthesis is coupled to the cell's metabolic and environmental status.
regulation of DNA biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ORC2 | Developmental defects, cancer | Knockout and point-mutation cell lines |
| FOXO | Cancer, aging, diabetes | Knock-in of mutant alleles |
| RRM1 | Cancer chemoresistance | Overexpression and knockout models |
| TYMS | Cancer, drug resistance | Point mutations for antifolate resistance |
| SUMO enzymes | Cancer, neurodegeneration | Knockout and tagged knock-in |
Cancer
Dysregulation of DNA biosynthetic process is a hallmark of cancer. Oncogenic signaling drives increased nucleotide biosynthesis and replication licensing, supporting uncontrolled proliferation. Overexpression of nucleotide biosynthetic enzymes such as RRM1 and TYMS is associated with chemoresistance. Targeting regulators of DNA synthesis is a major therapeutic strategy.
Developmental disorders
Mutations in genes controlling DNA replication licensing, such as ORC2, can cause developmental defects due to impaired DNA synthesis and genome instability. Chromatin remodeling defects also impact DNA biosynthesis and contribute to developmental syndromes.
Metabolic and degenerative diseases
Altered nucleotide metabolism links DNA biosynthetic regulation to metabolic syndromes and neurodegeneration. FoxO-mediated regulation is implicated in aging and degenerative processes. Metal dyshomeostasis can affect DNA synthesis through co-regulatory mechanisms.
From regulation of DNA biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate DNA synthesis rate? | CRISPR knockout followed by EdU incorporation |
| Does a point mutation in ORC2 affect licensing? | Point-mutation knock-in cell lines |
| Can overexpression of RRM1 drive chemoresistance? | Overexpression cell models |
| Where does protein Y localize during S phase? | Tagged knock-in with fluorescent tag |
| What is the effect of SUMOylation on chromatin? | Knockout of SUMO enzymes |
| How do transcription factors regulate DNA synthesis genes? | CRISPR knockout and RNA-seq |
How to Study the regulation of DNA biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU incorporation | Rate of DNA synthesis | Proliferation assays |
| CRISPR knockout screen | Gene essentiality for DNA synthesis | Identify novel regulators |
| RNA-seq | Transcriptional changes in DNA synthesis genes | Pathway analysis |
| ChIP-seq | Transcription factor binding to DNA synthesis genes | Regulatory network mapping |
| Proteomics | Protein interactions in replication complexes | ORC interactome |
| Live-cell imaging | Replication fork dynamics | Tagged knock-in models |
| Metabolomics | Nucleotide pool sizes | Nucleotide biosynthesis regulation |
EdU/BrdU incorporation assays
These assays measure DNA synthesis by detecting incorporation of thymidine analogs into newly synthesized DNA. They are used to quantify the rate of DNA biosynthesis after genetic perturbation.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify regulators of DNA biosynthetic process by selecting for cells with altered proliferation or DNA synthesis.
Proteomics and interactomics
Mass spectrometry-based approaches reveal protein complexes involved in DNA synthesis regulation, such as ORC and MCM complexes.
Imaging and live-cell tracking
Fluorescent tagging of replication proteins allows real-time visualization of DNA synthesis dynamics and regulation.
How CRISPR Can Be Used to Study GO:2000278 regulation of DNA biosynthetic process
Knockout
CRISPR knockout of candidate regulators of DNA biosynthetic process allows assessment of their essentiality and impact on DNA synthesis rate. For example, ORC2 knockout leads to replication defects and altered chromatin. Knockout of nucleotide biosynthetic enzymes reduces dNTP pools and impairs DNA synthesis.
Point Mutation
Point mutations can be introduced to model disease-associated variants or to dissect functional domains. For instance, point mutations in FOXO alter its ability to regulate DNA synthesis and cell cycle. Point mutations in RRM1 can confer resistance to inhibitors.
Knock-in
Knock-in of tagged versions of replication proteins enables imaging and proteomic studies. Tagged ORC2 knock-in allows tracking of licensing dynamics. Knock-in of fluorescent reporters for DNA synthesis genes facilitates live-cell analysis.
Overexpression
Overexpression of regulators such as RRM1 or TYMS can drive increased DNA synthesis and chemoresistance, modeling cancer phenotypes. Overexpression of CDT1 causes re-replication and genome instability.
How EDITGENE Supports regulation of DNA biosynthetic process Research
Researchers studying regulation of DNA biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in DNA synthesis, and to dissect the precise mechanisms by which it acts. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of DNA biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CDKN1A Knockout HEK293 Cell Line | EDJ-KQ129 | Human | 1026 | Details Get a Quote |
| PDGFA Knockout HEK293 Cell Line | EDJ-KQ1197 | Human | 5154 | Details Get a Quote |
| JADE3 Knockout HEK293 Cell Line | EDJ-KQ6737 | Human | 9767 | Details Get a Quote |
| TOM1L1 Knockout HEK293 Cell Line | EDJ-KQ6873 | Human | 10040 | Details Get a Quote |
| JADE2 Knockout HEK293 Cell Line | EDJ-KQ7976 | Human | 23338 | Details Get a Quote |
| ING5 Knockout HEK293 Cell Line | EDJ-KQ10053 | Human | 84289 | Details Get a Quote |
| ING4 Knockout HEK293 Cell Line | EDJ-KQ10950 | Human | 51147 | Details Get a Quote |
| JADE1 Knockout HEK293 Cell Line | EDJ-KQ13876 | Human | 79960 | Details Get a Quote |
| KAT7 Knockout HEK293 Cell Line | EDJ-KQ13885 | Human | 11143 | Details Get a Quote |
| MEAF6 Knockout HEK293 Cell Line | EDJ-KQ14227 | Human | 64769 | Details Get a Quote |
| JADE3 Knockout HCT 116 Cell Line | EDJ-KQ31133 | Human | 9767 | Details Get a Quote |
| JADE3 Knockout HeLa Cell Line | EDJ-KQ31134 | Human | 9767 | Details Get a Quote |
| ING5 Knockout HCT 116 Cell Line | EDJ-KQ37087 | Human | 84289 | Details Get a Quote |
| ING5 Knockout HeLa Cell Line | EDJ-KQ37088 | Human | 84289 | Details Get a Quote |
| MEAF6 Knockout HeLa Cell Line | EDJ-KQ42981 | Human | 64769 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About regulation of DNA biosynthetic process
What is GO:2000278 regulation of DNA biosynthetic process?
GO:2000278 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of DNA biosynthetic process.
What genes are involved in regulation of DNA biosynthetic process?
Key genes include ORC2, FOXO, nuclear receptors, SUMO machinery, DNA methyltransferases and nucleotide biosynthetic enzymes.
How is DNA biosynthetic process regulated?
It is regulated by nucleotide availability, replication licensing, chromatin state, transcription factors and signaling pathways.
Why is regulation of DNA biosynthetic process important in cancer?
Dysregulation leads to uncontrolled proliferation and chemoresistance, making it a therapeutic target.
What experimental methods study GO:2000278?
EdU incorporation, CRISPR screens, RNA-seq, ChIP-seq, proteomics and live-cell imaging are commonly used.
What is the role of ORC2 in DNA biosynthesis?
ORC2 is a licensing factor that also regulates epigenetics and chromosome structure, impacting DNA synthesis capacity.
How do nucleotide pools regulate DNA synthesis?
Nucleotide biosynthesis provides dNTP precursors, and its regulation matches supply to demand for DNA synthesis.
Can CRISPR be used to study regulation of DNA biosynthetic process?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models enable causal studies of regulators.
What diseases are linked to defects in DNA biosynthetic regulation?
Cancer, developmental disorders, metabolic syndromes and degenerative diseases.
How does chromatin remodeling affect DNA biosynthesis?
Chromatin remodeling and SUMOylation alter DNA accessibility and replication efficiency.
Conclusion
Regulation of DNA biosynthetic process (GO:2000278) is a critical biological process that integrates metabolic, signaling and chromatin inputs to control DNA synthesis. Its dysregulation underlies cancer and developmental disorders, and it offers numerous targets for therapeutic intervention. Advances in CRISPR technology and omics methods continue to unravel the complex regulatory networks, providing new opportunities for research and drug discovery.
References
- 1. Lane AN et al.. 2015. Regulation of mammalian nucleotide metabolism and biosynthesis.. Nucleic Acids Res 43(4):2466-85 PMID: 25628363
- 2. Weikum ER et al.. 2018. The nuclear receptor superfamily: A structural perspective.. Protein Sci 27(11):1876-1892 PMID: 30109749
- 3. Mahendrawada L et al.. 2025. Low overlap of transcription factor DNA binding and regulatory targets.. Nature 642(8068):796-804 PMID: 40240607
- 4. Chakraborty UK et al.. 2024. A 'through-DNA' mechanism for co-regulation of metal uptake and efflux.. Nat Commun 15(1):10555 PMID: 39632925
- 5. Chandler LA et al.. 1988. Hypomethylation of DNA in the regulation of gene expression.. Dev Biol (N Y 1985) 5:335-49 PMID: 2481475
- 6. Wotton D et al.. 2017. SUMO and Chromatin Remodeling.. Adv Exp Med Biol 963:35-50 PMID: 28197905
- 7. Calnan DR et al.. 2008. The FoxO code.. Oncogene 27(16):2276-88 PMID: 18391970
- 8. Su Z et al.. 2025. Regulation of epigenetics and chromosome structure by human ORC2.. Cell Rep 44(6):115816 PMID: 40504688
